Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Oral capsules of 100 mg Ferrula assa-foetida for 3 months twice a day. Intervention 2: Oral capsules of 100 mg Fennle for 3 months twice a day. Intervention 3: Oral capsules of 100 mg
Treatment - Drugs
Oral capsules of 100 mg Ferrula assa-foetida for 3 months twice a day
Oral capsules of 100 mg Fennle for 3 months twice a day
Oral capsules of 100 mg placebo for 3 months twice a day
Sponsors
Jahrom univercity of medical scinces
Eligibility
Sex/Gender
Female
Age
15 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: student girls aged 15-30 years were complained of oligo/amenorrhea; hirsutism score =8 based on Ferriman-Galway scale. Exclusion criteria: history of medical treatment from 3 months age; participation in another study; no willing to participate in this study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pcos syndrom. Timepoint: befor intervention,third after intervention. Method of measurement: sonography,freriman-galway(f-g scale),hormonal changes.;Improving PCOs symptoms. Timepoint: before the study, 3 month after the study. Method of measurement: Hormonal chnges, sonography parameters, Ferriman-Galway (F-G scale) score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sonographic data. Timepoint: before the intervention, 3 months after the intervention. Method of measurement: Sonography system.;Hirsotism Score of Freman-Galway. Timepoint: before the intervention. Method of measurement: Questionnaire of Freman_Galway.;Hormonal changes. Timepoint: before the intervention, 3 months after the intervention. Method of measurement: Elisa Methode. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactfatemeh Ghavi
Jahrom University of Medical Sciences
Outcome results
None listed